Epithelial-Mesenchymal Transition Induced in Cancer Cells by Adhesion to Type I Collagen
Overview
Chemistry
Molecular Biology
Authors
Affiliations
The epithelial-mesenchymal transition (EMT) is an important biological process that is physiologically observed during development, wound healing, and cancer invasion. During EMT induction, cancer cells lose their epithelial properties owing to various tumor microenvironmental factors and begin to exhibit mesenchymal properties, such as loss of apical-basal polarity, weakened intercellular adhesion, and promotion of single cell migration. Several factors, including growth factor stimulation and adhesion to type I collagen (Col-I), induce EMT in cancer cells. Cells adhere to Col-I via specific receptors and induce EMT by activating outside-in signals. In vivo, Col-I molecules often form fibrils, which then assemble into supramolecular structures (gel form). Col-I also self-assembles in vitro under physiological conditions. Notably, Col-I can be used as a culture substrate in both gel and non-gel forms, and the gel formation state of Col-I affects cell fate. Although EMT can be induced in both forms of Col-I, the effects of gel formation on EMT induction remain unclear and somewhat inconsistent. Therefore, this study reviews the relationship between Col-I gel-forming states and EMT induction in cancer cells.
Zhang J, Wang Y, Liu Y, Chen H, Chai N, Zhao Y BMC Cancer. 2025; 25(1):231.
PMID: 39930421 PMC: 11812265. DOI: 10.1186/s12885-025-13657-4.
Post-Translational Modifications of Proteins Orchestrate All Hallmarks of Cancer.
Bruno P, Arshad A, Gogu M, Waterman N, Flack R, Dunn K Life (Basel). 2025; 15(1).
PMID: 39860065 PMC: 11766951. DOI: 10.3390/life15010126.
Qu J, Cheng X, Liu M, Zhang Q Transl Cancer Res. 2024; 13(11):6347-6363.
PMID: 39697757 PMC: 11651744. DOI: 10.21037/tcr-24-2159.
Hypoxia inducible factor-1ɑ as a potential therapeutic target for osteosarcoma metastasis.
Zhou J, Lan F, Liu M, Wang F, Ning X, Yang H Front Pharmacol. 2024; 15:1350187.
PMID: 38327979 PMC: 10847273. DOI: 10.3389/fphar.2024.1350187.